Loading

Press Releases

Press Releases

  1. ProBioGen Signs next GlymaxX® ADCC Technology Deal with TOP 10 Pharma Company for Therapeutic Antibody Platform

    PDF Download

  2. ProBioGen Launches Unique Portfolio of Engineered High-Performance Cell Lines for Biopharmaceutical Manufacturing

    PDF Download

  3. ProBioGen Introduces Novel Productivity-Boosting Technology for Therapeutic Protein Production: "Pathway Modulator"

    PDF Download

  4. Ceva Takes Commercial License for ProBioGen's AGE1.CR® Cell Line for Viral Vaccine Production

    PDF Download

  5. ProBioGen and Inhibrx Sign License Deal on GlymaxX® ADCC Technology for Therapeutic Antibodies Development

    PDF Download

  6. Boehringer Ingelheim licenses ProBioGen's novel GlymaxX Technology

    PDF Download